These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2754804)

  • 1. [FDP-E--quantitative analysis by LPIA (latex photometric immunoassay) method].
    Furusaki F; Sudo T; Tsutsui S
    Rinsho Byori; 1989 Apr; Spec No 81():168-75. PubMed ID: 2754804
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent progress on analysis of blood coagulation factors and fibrinolytic agents; FDP D dimer analysis using NANOPIA FDP].
    Matsumoto T; Sakai Y; Maeda M; Takei F
    Rinsho Byori; 1989 Apr; Spec No 81():183-8. PubMed ID: 2754806
    [No Abstract]   [Full Text] [Related]  

  • 3. Measurement of urinary fibrin/fibrinogen degradation products by latex photometric immunoassay.
    Kaizu K; Ito Y; Uriu K; Eto S
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):23-8. PubMed ID: 8336396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of urinary fibrin/fibrinogen degradation products (FDP) as measured by latex photometric immunoassay in renal diseases.
    Kaizu K; Ito Y; Uriu K; Eto S
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):29-34. PubMed ID: 8336397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum FDP assay with latex photometric immunoassay and its analysis by immunoblotting].
    Okumura N; Kagiya H; Saito H; Katsuyama T; Kanai M
    Rinsho Byori; 1991 Jan; 39(1):76-82. PubMed ID: 2008047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of urinary FDP-E measured by latex photometric immunoassay (LPIA) in the renal disease].
    Kaizu K; Ito Y; Uriu K; Komine N; Hashimoto O; Eto S
    Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):365-71. PubMed ID: 1875556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
    Chen JP; Williams TK; Legendre AM
    Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of D Dimer analysis in blood coagulation and fibrinolysis tests].
    Kurokawa I; Kondo H
    Nihon Rinsho; 1989 Dec; 48 Suppl():901-5. PubMed ID: 2695675
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical significance of FDP-E analysis in blood coagulation and fibrinolysis tests].
    Horiuchi N; Aoki Y; Terada H
    Nihon Rinsho; 1989 Dec; 48 Suppl():896-900. PubMed ID: 2622026
    [No Abstract]   [Full Text] [Related]  

  • 10. Prototype quantitative assay for fibrinogen/fibrin degradation products. Clinical evaluation.
    Sigal SH; Cembrowski GS; Shattil SJ; Brown NM; Schifreen RS; Schwartz MW
    Arch Intern Med; 1987 Oct; 147(10):1790-3. PubMed ID: 3662708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [FDP-D dimer and FDP-E fraction (FDP-E)].
    Amemiya N
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():608-10. PubMed ID: 15658402
    [No Abstract]   [Full Text] [Related]  

  • 12. [Analysis of FDP].
    Ikematsu S; Kuroso K
    Rinsho Byori; 1985 Feb; Spec No 61():86-96. PubMed ID: 3889425
    [No Abstract]   [Full Text] [Related]  

  • 13. [Quantitative analysis of crosslinked fibrin degradation products (XDP) in several diseases].
    Saito M; Asakura H; Ito K; Joukaji H; Uotani C; Kumabashiri I; Matsuda T
    Rinsho Ketsueki; 1988 Nov; 29(11):2042-7. PubMed ID: 3236412
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
    Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
    Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fibrin/fibrinogen degradation products (FDP)].
    Kuroso K; Fujimaki M
    Nihon Rinsho; 1989 Dec; 48 Suppl():892-5. PubMed ID: 2622025
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fibrin x fibrinogen degradation products (FDP)].
    Mori Y; Wada H
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():604-7. PubMed ID: 15658401
    [No Abstract]   [Full Text] [Related]  

  • 17. [A new method for determination of DD/E complex using latex agglutination].
    Soe G; Kohno I; Motojima M; Saito M; Matsuda M; Terukina S
    Rinsho Byori; 1989 Apr; Spec No 81():176-82. PubMed ID: 2754805
    [No Abstract]   [Full Text] [Related]  

  • 18. [Quantitative evaluation of fibrinogen-fibrin degradation products (FDP) in the blood of full-term newborn infants, using the staphylococcal clumping test].
    Schettini F; Altomare M; Mautone A
    Boll Soc Ital Biol Sper; 1976 Feb; 52(3):121-6. PubMed ID: 949391
    [No Abstract]   [Full Text] [Related]  

  • 19. A latex immunoassay of fibrin/fibrinogen degradation products in plasma using a monoclonal antibody.
    Mirshahi M; Soria J; Soria C; Perrot JY; Boucheix C
    Thromb Res; 1986 Dec; 44(6):715-28. PubMed ID: 3798417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and possible reasons for discordant results between positive FDP and negative D-dimer latex assays in clinical specimens.
    Song KS; Kim YA; Kim HK; Park Q
    Yonsei Med J; 1999 Apr; 40(2):107-11. PubMed ID: 10333712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.